Shree Ganesh Bio-Tech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
For the six months, sales was INR 123.72 million compared to INR 424.04 million a year ago. Revenue was INR 123.72 million compared to INR 423.84 million a year ago. Net income was INR 2.25 million compared to INR 23.49 million a year ago. Basic earnings per share from continuing operations was INR 0.01 compared to INR 0.06 a year ago. Diluted earnings per share from continuing operations was INR 0.01 compared to INR 0.06 a year ago.